ArticleWorld journal of hepatology2016

Adjuvant sorafenib in hepatocellular carcinoma: A cautionary comment of STORM trial.

Jian-Hong Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.